LCM
IBB icon

Lucas Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Lucas Capital Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$4.16M Sell
27,446
-1,162
-4% -$166K 4.85% 6
2020
Q3 		$3.87M Buy
28,608
+110
+0.4% +$14.9K 5.19% 6
2020
Q2 		$3.9M Sell
28,498
-1,025
-3% -$131K 5.33% 6
2020
Q1 		$3.18M Buy
29,523
+170
+0.6% +$19.6K 4.81% 6
2019
Q4 		$3.54M Sell
29,353
-575
-2% -$64.2K 4.19% 7
2019
Q3 		$2.98M Sell
29,928
-347
-1% -$36.3K 3.8% 8
2019
Q2 		$3.3M Buy
30,275
+15
+0% +$1.6K 3.91% 6
2019
Q1 		$3.38M Buy
30,260
+632
+2% +$69.3K 3.99% 4
2018
Q4 		$2.86M Sell
29,628
-367
-1% -$39K 3.76% 5
2018
Q3 		$3.66M Sell
29,995
-407
-1% -$47.9K 4.43% 4
2018
Q2 		$3.34M Buy
30,402
+71
+0.2% +$7.59K 3.16% 6
2018
Q1 		$3.12M Sell
30,331
-20
-0.1% -$2.22K 3.02% 9
2017
Q4 		$3.24M Buy
30,351
+72
+0.2% +$7.7K 2.81% 9
2017
Q3 		$3.37M Buy
30,279
+885
+3% +$94.6K 3.02% 8
2017
Q2 		$3.04M Buy
29,394
+6,339
+27% +$624K 2.2% 13
2017
Q1 		$2.25M Sell
23,055
-5,400
-19% -$517K 1.67% 21
2016
Q4 		$2.52M Buy
28,455
+1,302
+5% +$119K 1.82% 18
2016
Q3 		$2.62M Buy
27,153
+588
+2% +$55.9K 2.01% 17
2016
Q2 		$2.28M Buy
26,565
+399
+2% +$35.8K 1.61% 22
2016
Q1 		$2.27M Buy
26,166
+339
+1% +$30.3K 1.66% 20
2015
Q4 		$2.91M Buy
25,827
+1,491
+6% +$162K 1.87% 16
2015
Q3 		$2.46M Buy
24,336
+255
+1% +$30.6K 1.43% 23
2015
Q2 		$2.96M Buy
24,081
+39
+0.2% +$4.67K 1.32% 28
2015
Q1 		$2.75M Buy
24,042
+378
+2% +$41.7K 1.11% 36
2014
Q4 		$2.39M Sell
23,664
-570
-2% -$55.4K 0.89% 42
2014
Q3 		$2.21M Sell
24,234
-3,870
-14% -$340K 0.68% 51
2014
Q2 		$2.41M Buy
+28,104
New +$2.21M 0.76% 47

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return

Lucas Capital Management's IBB Position: Q4 2020 in Review

Lucas Capital Management reduced its iShares Biotechnology ETF (IBB) stake by 4.1% in Q4 2020, selling an estimated $166K and leaving 27,446 shares worth $4.16M. The position accounts for 4.85% of the portfolio, ranked #6.

Lucas Capital Management first reported a position in IBB in Q2 2014 and has held it in 27 quarters since. 856 funds tracked by Wall St. Rank hold IBB as of Q4 2020.

  • Lucas Capital Management held 27,446 shares of iShares Biotechnology ETF worth $4.16M as of Q4 2020.
  • Lucas Capital Management sold 1,162 iShares Biotechnology ETF shares in Q4 2020, an estimated $166K.
  • iShares Biotechnology ETF made up 4.85% of Lucas Capital Management's portfolio in Q4 2020, its #6 holding.
  • Lucas Capital Management first reported a position in iShares Biotechnology ETF in Q2 2014 and has held it in 27 quarters since.
  • 856 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2020.

Based on Lucas Capital Management's 13F filing for Q4 2020, filed 27 Jan 2021.